Mirae Asset Global Investments
LEGN icon

Mirae Asset Global Investments’s Legend Biotech LEGN Stock Holding History

Mirae Asset Global Investments’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Sell
7,485
-3,638
-33% -$98.1K ﹤0.01% 1108
2026
Q1 		$201K Buy
11,123
+12
+0.1% +$229 ﹤0.01% 1070
2025
Q4 		$242K Sell
11,111
-1,101
-9% -$31.5K ﹤0.01% 1117
2025
Q3 		$398K Sell
12,212
-2,725
-18% -$101K ﹤0.01% 1022
2025
Q2 		$530K Sell
14,937
-989,397
-99% -$32.1M ﹤0.01% 935
2025
Q1 		$216K Buy
1,004,334
+989,635
+6,733% +$35.5M ﹤0.01% 1036
2024
Q4 		$479K Sell
14,699
-13,850
-49% -$574K ﹤0.01% 953
2024
Q3 		$1.39M Sell
28,549
-13,151
-32% -$701K 0.01% 735
2024
Q2 		$1.85M Buy
41,700
+15,749
+61% +$727K 0.01% 597
2024
Q1 		$1.4M Sell
25,951
-34,541
-57% -$2.08M ﹤0.01% 1361
2023
Q4 		$3.64M Buy
+60,492
New +$3.83M 0.01% 1009

Other funds holding LEGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TPSF
Texas Permanent School Fund Austin, Texas $2.26B AUM 7.02% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Mirae Asset Global Investments's LEGN Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Legend Biotech (LEGN) stake by 33% in Q2 2026, selling an estimated $98.1K and leaving 7,485 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Mirae Asset Global Investments first reported a position in LEGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.64M in Q4 2023. 31 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Mirae Asset Global Investments held 7,485 shares of Legend Biotech worth $216K as of Q2 2026.
  • Mirae Asset Global Investments sold 3,638 Legend Biotech shares in Q2 2026, an estimated $98.1K.
  • Legend Biotech made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1108 holding.
  • Mirae Asset Global Investments first reported a position in Legend Biotech in Q4 2023 and has held it in 11 quarters since.
  • Mirae Asset Global Investments's Legend Biotech position peaked at $3.64M in Q4 2023.
  • 31 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.